APLS

Apellis Pharmaceuticals

Delisted

APLS was delisted on the 13th of May, 2026.

Buy
Hold
Sell

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$31
24% downside
High target

7 analyst ratings

positive
neutral
43%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
Roth Capital
Roth Capital
Adam Walsh
100% 1-yr APLS win rate
13 Mar ‘26 2 months ago
JP Morgan
JP Morgan
Anupam Rama
0% 1-yr APLS win rate
5 Mar ‘26 2 months ago
Mizuho
Mizuho
Graig Suvannavejh
5 Mar ‘26 2 months ago
Citigroup
Citigroup
Yigal Nochomovitz
60% 1-yr APLS win rate
25 Feb ‘26 2 months ago
RBC Capital
RBC Capital
Lisa Walter
25 Feb ‘26 2 months ago
Wedbush
Wedbush
Laura Chico
25 Feb ‘26 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
50% 1-yr APLS win rate
25 Feb ‘26 2 months ago